Additional cytogenetic alterations in TCP-ALL include fusion genes encoding chimeric oncogenic proteins, such as SIL-TAL1 and MLL, which, in some studies, have been associated with favorable clinical outcomes [17]. Here, TAL1 is linked to acute lymphoblastic leukemia.